Michael A. (Tony) Hollingsworth, Ph.D.
Associate Director for Basic Research
Fred & Pamela Buffett Cancer Center
University of Nebraska Medical Center
Omaha, Nebraska

“Immunosuppression in pancreatic cancer” 
July 20 - 7:00 p.m.

Sudipta Seal, Ph.D.
Professor and Chair, Materials Science and Engineering
University of Central Florida
Orlando, Florida

“Development of long-lasting nanozymes for pathogen deactivation”
July 20 1:45 p.m.

Tatiana Bronich, Ph.D.
Associate Dean, Bouvé College of Health Sciences;
Dean, School of Pharmacy and Pharmaceutical Sciences
Northeastern University
Boston, Massachusetts

“Engineering of soft nanomaterials for combination cancer therapy”
July 20 2:30 p.m.

Igor Roninson, Ph.D.
Professor and Director, Center for Targeted Therapeutics
College of Pharmacy
University of South Carolina
Columbia, South Carolina

“Targeting Transcriptional Reprogramming for Cancer Therapy”
July 20 10:45 a.m.

Randall Brand, MD
Professor of Medicine and Director, GI Malignancy Early Detection, Diagnosis & Prevention Program
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania

“Current Status of Early Detection of Pancreatic Adenocarcinoma”
July 20 3:45 p.m.

Luke Theogarajan, Ph.D.
Professor and Vice-Chair, Electrical and Computer Engineering
University of California
Santo Barbara, California

“Cell and Lattice-Based Modeling for Cancer Biology”
July 20 11:30 a.m.

Pradeep Dhal, Ph.D.
Senior R & D Director within Early Development, Synthetics Platform organization
Sanofi Global Research and Development
Bridgewater, New Jersey

“Antibody-Drug Conjugates as Targeted Cancer Therapies:  Recent Developments in Linker and Conjugation Chemistries”
July 21 8:30 a.m.

Sandro da Rocha, Ph.D.
Professor, Director of Pharmaceutical Engineering
Virginia Commonwealth University
Richmond, Virginia

“Remodeling the Lung Tumor Microenvironment with Locally Administered Immunochemotherapies”
July 20, 9:30 a.m.